Vaccines can help minimize certain diseases
Search results for: juvenile idiopathic arthritis
Know Your Labs, Part 2
A review of testing for rheumatoid arthritis
A Regulatory Leader in Rheumatology
Jeffrey Siegel, MD: A rare combination of clinical scientist and regulatory collaborator
Nature’s Inflammation Experiment
Familial Mediterranean fever a frequently misdiagnosed autoinflammatory disease
Watch Those Eyes
What you need to know about Uveitis in Rheumatic Diseases
Pursue Remission
Disease remission should be the goal for all rheumatologists treating childhood arthritis
State-of-the-Art Care for Your Practice
Clinical updates from the ACR Symposium
Science from our Sisters
Recommended reading from A&R and AC&R
A Day in the Life of Gay Kuchta, OT
Treating children with rheumatologic diseases takes a unique approach. “You shouldn’t treat them as little adults,” says Gay Kuchta, OT, who works in pediatrics at the Mary Pack Arthritis Program at Vancouver Hospital in British Columbia. “They take special consideration.”
AC&R Study Summary: Standardizing Treatment for Moderately Severe JDM
Why was this study done? Juvenile dermatomyositis (JDM) is the most common type of idiopathic inflammatory myopathy in childhood, and most patients have a chronic disease course requiring prolonged administration of systemic glucocorticoids and immunosuppressive agents. The initial management for patients with moderately severe JDM is relatively standardized, typically including methotrexate and systemic glucocorticoids with…
- « Previous Page
- 1
- …
- 31
- 32
- 33
- 34
- 35
- 36
- Next Page »